| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245542 Isolated protein comprising a polypeptide having a specific amino acid sequence; targets or screening for antibiotics and bactericides; agonist or antagonists; respiratory system disorders |
| 06/12/2001 | US6245540 Human choline acetyltransferase |
| 06/12/2001 | US6245531 Polynucleotide encoding insect ecdysone receptor |
| 06/12/2001 | US6245530 Receptor ligand |
| 06/12/2001 | US6245529 Testis-specific cystatin-like protein cystatin T |
| 06/12/2001 | US6245527 Nucleotide sequence which encodes preferential platelet receptors; for the diagnosis and treatment of atherosclerosis, cardiovascular disorders and tumor metastasis; antitumor agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245502 Target system |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245334 Polypeptide containing lecithin |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | US6245320 Inhibition of mucin release from airway goblet cells by polycationic peptides |
| 06/12/2001 | CA2203689C Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2117477C Multivalent single chain antibodies |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA2044978C Platelet-aggregation inhibitor |
| 06/12/2001 | CA2043953C Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant dna and transformed microorganisms |
| 06/12/2001 | CA1341253C Human ifn-.beta.2/il-6, its purification and use |
| 06/12/2001 | CA1341252C Human interferon-.beta.2a and interferon-.beta.2b; vectors containing genes coding for said interferons: cell lines producing same and use of said interferons as pharmaceuticals |
| 06/12/2001 | CA1341250C Method for inducing biological coverings in wounds |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040494A1 Drug inducible system and use thereof |
| 06/07/2001 | WO2001040486A1 Novel polypeptide---human atp-dependent serine protease 48 and polynucleotide encoding it |
| 06/07/2001 | WO2001040485A1 Novel polypeptide-ef-chiral calcium-binding protein 62 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040484A2 A novel polypeptide, a human atp-dependent serine protease 64 and the polynucleotide encoding the polypeptide |
| 06/07/2001 | WO2001040483A1 Novel polypeptide---human lipoprotein 105 containing cytochrome c structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040481A1 Novel polypeptide -- human neuro:transmitter co-transporter membrane protein 13 and polynucleotide encoding it |
| 06/07/2001 | WO2001040479A1 Novel polypeptide, ef-chiral calcium-binding protein 96 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040477A1 Transposase and method of gene modification |
| 06/07/2001 | WO2001040475A2 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040469A2 Tick antigens and compositions and methods comprising them |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040466A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040464A1 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/07/2001 | WO2001040463A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040449A2 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040439A2 CLONING AND EXPRESSION OF A DNA SEQUENCE ENCODING A 41 kDa CRYPTOSPORIDIUM PARVUM OOCYST WALL PROTEIN |
| 06/07/2001 | WO2001040438A2 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | WO2001040313A2 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 06/07/2001 | WO2001040311A1 Chemokine slc-il2 fused protein and gene thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040301A2 A gene, disrupted in schizophrenia |
| 06/07/2001 | WO2001040300A2 Protease resistant tumor suppressor p14(arf) |
| 06/07/2001 | WO2001040299A1 A novel polypeptide - human prolipoprotein signal peptide 14 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040298A1 A new polypeptide - human protein kinase 9 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040297A1 A novel polypeptide - human atp/gtp binding domain-containing transition nuclear protein 10 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040296A1 A novel polypeptide - human cytochrome c domain-containing tnfr/ngfr protein 51 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040295A1 A new polypeptide - human zinc finger protein 48 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040294A1 A novel polypeptide - human thrombospondin-30 and a polynucleoti de encoding the same |
| 06/07/2001 | WO2001040293A2 Method of modulating proapoptotic and antiapoptotic pathways in cells |
| 06/07/2001 | WO2001040292A1 Antigen-binding fragments specific for tumor associated antigens |
| 06/07/2001 | WO2001040291A2 Proteins and nucleic acids encoding the same |
| 06/07/2001 | WO2001040289A1 A novel polypeptide - mitochondrial carrier 12 and polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040288A1 A novel polypeptide-human uteroglobin 13 and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040287A1 A novel polypeptide-beta subunit 10 of sodium pump and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040286A1 A human brain expressed x-linked protein and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040285A1 A novel polypeptide - human protein kinase 38 and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040284A1 A novel polypeptide-human prolipoprotein signal peptide 11 and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040283A1 A NOVEL POLYPEPTIDE - HUMAN ATP/GTP BINDING DOMAIN CONTAINING ACYL-CoA DEHYDROGENASE 11 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040281A2 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040277A2 Carbohydrate-aminated glycoproteins |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040275A2 Peptides that stabilize protein antigens and enhance presentation to cd8+ t cells |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040270A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 06/07/2001 | WO2001040269A2 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2001040267A2 Proteoglycans and pharmaceutical compositions comprising them |
| 06/07/2001 | WO2001040264A2 Peptide antigens |
| 06/07/2001 | WO2001040263A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040262A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | WO2001040259A2 Monkey orexin 1 receptor |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001040252A1 Monkey calcium sensing receptor |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040247A1 Interleukin-1 homologue, mat il-1h4 |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
| 06/07/2001 | WO2001040142A2 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 06/07/2001 | WO2001039803A2 Interleukin-1 muteins useful as vaccine adjuvants |